Dorchester Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.2M | Buy |
6,745
+190
| +3% | +$34.9K | 0.24% | 66 |
|
|
2024
Q3 | $1.29M | Buy |
6,555
+1,300
| +25% | +$243K | 0.24% | 65 |
|
|
2024
Q2 | $901K | Sell |
5,255
-1,150
| -18% | -$190K | 0.17% | 77 |
|
|
2024
Q1 | $1.17M | Sell |
6,405
-900
| -12% | -$155K | 0.21% | 75 |
|
|
2023
Q4 | $1.13M | Buy |
7,305
+373
| +5% | +$54.4K | 0.21% | 72 |
|
|
2023
Q3 | $1.03M | Sell |
6,932
-375
| -5% | -$55.1K | 0.21% | 75 |
|
|
2023
Q2 | $984K | Sell |
7,307
-250
| -3% | -$36.7K | 0.2% | 69 |
|
|
2023
Q1 | $1.2M | Buy |
7,557
+5,782
| +326% | +$884K | 0.25% | 63 |
|
|
2022
Q4 | $287K | Sell |
1,775
-5,182
| -74% | -$795K | 0.07% | 119 |
|
|
2022
Q3 | $934K | Sell |
6,957
-650
| -9% | -$93.3K | 0.21% | 76 |
|
|
2022
Q2 | $1.17M | Buy |
7,607
+2,420
| +47% | +$370K | 0.23% | 67 |
|
|
2022
Q1 | $1.05M | Sell |
5,187
-600
| -10% | -$87.2K | 0.17% | 73 |
|
|
2021
Q4 | $784K | Sell |
5,787
-500
| -8% | -$59.1K | 0.16% | 74 |
|
|
2021
Q3 | $678K | Sell |
6,287
-200
| -3% | -$22.9K | 0.17% | 75 |
|
|
2021
Q2 | $731K | Sell |
6,487
-48
| -0.7% | -$5.41K | 0.17% | 71 |
|
|
2021
Q1 | $707K | Hold |
6,535
| – | – | 0.18% | 73 |
|
|
2020
Q4 | $700K | Hold |
6,535
| – | – | 0.19% | 72 |
|
|
2020
Q3 | $572K | Sell |
6,535
-100
| -2% | -$9.41K | 0.18% | 70 |
|
|
2020
Q2 | $651K | Sell |
6,635
-400
| -6% | -$35.2K | 0.21% | 70 |
|
|
2020
Q1 | $536K | Hold |
7,035
| – | – | 0.2% | 70 |
|
|
2019
Q4 | $623K | Hold |
7,035
| – | – | 0.17% | 72 |
|
|
2019
Q3 | $533K | Sell |
7,035
-150
| -2% | -$10.3K | 0.16% | 77 |
|
|
2019
Q2 | $522K | Sell |
7,185
-1,558
| -18% | -$122K | 0.15% | 78 |
|
|
2019
Q1 | $705K | Sell |
8,743
-599
| -6% | -$49K | 0.22% | 60 |
|
|
2018
Q4 | $861K | Hold |
9,342
| – | – | 0.3% | 52 |
|
|
2018
Q3 | $884K | Hold |
9,342
| – | – | 0.27% | 52 |
|
|
2018
Q2 | $866K | Sell |
9,342
-100
| -1% | -$9.77K | 0.28% | 53 |
|
|
2018
Q1 | $894K | Sell |
9,442
-300
| -3% | -$33K | 0.3% | 51 |
|
|
2017
Q4 | $942K | Sell |
9,742
-100
| -1% | -$9.43K | 0.3% | 54 |
|
|
2017
Q3 | $875K | Hold |
9,842
| – | – | 0.28% | 60 |
|
|
2017
Q2 | $714K | Hold |
9,842
| – | – | 0.25% | 66 |
|
|
2017
Q1 | $641K | Buy |
9,842
+242
| +3% | +$15.2K | 0.22% | 67 |
|
|
2016
Q4 | $601K | Hold |
9,600
| – | – | 0.22% | 67 |
|
|
2016
Q3 | $605K | Hold |
9,600
| – | – | 0.23% | 66 |
|
|
2016
Q2 | $594K | Hold |
9,600
| – | – | 0.22% | 68 |
|
|
2016
Q1 | $548K | Hold |
9,600
| – | – | 0.21% | 69 |
|
|
2015
Q4 | $569K | Sell |
9,600
-200
| -2% | -$11.5K | 0.24% | 65 |
|
|
2015
Q3 | $712K | Hold |
9,800
| – | – | 0.26% | 58 |
|
|
2015
Q2 | $822K | Buy |
+9,800
| New | +$640K | 0.27% | 56 |
|
Other funds holding ABBV
Dorchester Wealth Management's ABBV Position: Q4 2024 in Review
Dorchester Wealth Management increased its AbbVie (ABBV) stake by 2.9% in Q4 2024, buying an estimated $34.9K and bringing the position to 6,745 shares worth $1.2M. The position accounts for 0.24% of the portfolio, ranked #66.
Dorchester Wealth Management first reported a position in ABBV in Q2 2015 and has held it in 39 quarters since. The position peaked at $1.29M in Q3 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.
- Dorchester Wealth Management held 6,745 shares of AbbVie worth $1.2M as of Q4 2024.
- Dorchester Wealth Management bought 190 AbbVie shares in Q4 2024, an estimated $34.9K.
- AbbVie made up 0.24% of Dorchester Wealth Management's portfolio in Q4 2024, its #66 holding.
- Dorchester Wealth Management first reported a position in AbbVie in Q2 2015 and has held it in 39 quarters since.
- Dorchester Wealth Management's AbbVie position peaked at $1.29M in Q3 2024.
- 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.
Based on Dorchester Wealth Management's 13F filing for Q4 2024, filed 4 Feb 2025.